Arphra/Issuer/WST

WST

West Pharmaceutical Services, Inc.

HealthcareMedical - Instruments & SuppliesUSUSD

$316.30

-0.23%LiveJun 01, 2026

AI Brief

Market cap

$22.35B

52w range

206.19 – 330.88

P / E

—

EPS

—

Volume

561.77K

Revenue · FY

$3.07B

+6.26% YoY

Explain this page

Arphra AIPlain-English read on West Pharmaceutical Services, Inc.’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

$17.59M

10 txns

Net flow

−$17.59M

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$298.66

Change

+42.63%

Period high

$309.70

Period low

$209.39

Period start

$209.392025-06-02

Through 2026-05-04

Peers

Price change · trailing returns

Live

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-2.02%	-0.31%	+5.19%	+24.36%	+15.38%	+14.96%	+51.06%	-7.39%	-7.01%	+320.67%	+28395.50%

Aftermarket

Live

Jun 01, 11:45 PM

Last trade

$317.56

973 sh

Bid

$285.19

100 sh

Ask

$330.00

100 sh

Spread

$44.810

Sector & industry today

Live

Sectors

Technology
+0.67%
Basic Materials
+0.15%
Communication Services
+0.13%
Real Estate
-0.13%
Industrials
-0.48%
Energy
-0.58%
Healthcare
-0.65%
Financial Services
-0.80%
Consumer Defensive
-0.85%
Consumer Cyclical
-0.85%
Utilities
-1.15%

Top industries (issuer's industry highlighted)

Medical - Instruments & Supplies
+1.72%
Computer Hardware
+8.35%
Software - Infrastructure
+7.61%
Coal
+5.76%
Consulting Services
+5.28%
Medical - Healthcare Information Services
+5.23%
Medical - Diagnostics & Research
+4.96%
REIT - Healthcare Facilities
-3.49%
Broadcasting
-3.48%
Software - Application
+3.44%
Advertising Agencies
+3.24%
Biotechnology
+3.22%

Fair value

Football field →

Weighted blend

$141.71

-55.20% vs spot

Recommendation

Sell

18 of 19 methods

Method spread

0bull18bear

±5% threshold

Analyst PT consensus: $315.83 (-0.15%)

Total assets

$4.27B

Total debt

$416.7M

Cash & equiv

$791.3M

Operating CF

$754.8M

Free cash flow

$468.9M

Buybacks

-$134M

Analyst view

DB · price_targets + analyst_grades

Consensus target

$315.83

-0.15% upside

Low

$295.00

Median

$315.00

High

$340.00

Recent actions

0 ↑0 ↓8 hold

Apr 01, 2026
Mar 01, 2026
Feb 01, 2026
Jan 01, 2026
Dec 01, 2025

News

DB · news_items

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q1 Mar 2026	$844.9M	$138.8M	$1.92
Q4 Dec 2025	$805M	$132.1M	$1.82
Q3 Sep 2025	$804.3M	$140M	$1.93
Q2 Jun 2025	$766.2M	$131.8M	$1.82
Q1 Mar 2025	$698.2M	$89.8M	$1.23
Q4 Dec 2024	$748.5M	$130.1M	$1.78

Recent insiders

All →

Insider	Action	Shares	Value	Date
Winters Chad officer: VP, Chief Accounting Officer	Sell	896	$269.4K	Apr 27, 2026
Favorite Annette F officer: Sr. VP & Chief HR Officer	Sell	2,817	$859.75K	Apr 27, 2026
Witherspoon Charles officer: VP & Treasurer	Sell	225	$69.84K	Oct 29, 2024
Witherspoon Charles officer: VP & Treasurer	Sell	478	$148.37K	Oct 29, 2024
Witherspoon Charles officer: VP & Treasurer	Sell	500	$150K	Aug 19, 2024
Witherspoon Charles officer: VP & Treasurer	Sell	529	$158.7K	Aug 19, 2024

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2025	$3.07B	$617.4M	$493.7M	$6.80	+16.06%
FY 2024	$2.89B	$594.6M	$492.7M	$6.69	+17.03%
FY 2023	$2.95B	$710.9M	$593.4M	$7.88	+20.11%
FY 2022	$2.89B	$763.5M	$585.9M	$7.73	+20.30%
FY 2021	$2.83B	$758.7M	$661.8M	$8.67	+23.38%